Oxytocin has been tried successfully with autism and recently was trialed with patients diagnosed with frontal temporal dementia, FTD. Social behavior is a common consequence of FTD, individuals can become emotionally blunted and withdrawn. Evidence in the use with autism is that it enhances “relatedness”. The hormone is thought to enhance positive cues from the environment and to reduce negative ones leading to decreased sensitivity to feeling threatened by the environment. Time and further research will provide confirmation of whether this drug could be of benefit to those diagnosed with FTD. Neurology Today 1-19-12.